Phenazopyridine Hydrochloride (Page 2 of 2)

ADVERSE REACTIONS

The following adverse events have been reported:

CNS: headache.

Gastrointestinal: nausea, vomiting and diarrhea.

Dermatologic and Hypersensitivity: rash, pruritus, discoloration, anaphylactoid-like reaction and hypersensitivity hepatitis.

Hematologic: methemoglobinemia, hemolytic anemia, potential hemolytic agent in G-6-PD deficiency, sulfhemoglobinemia.

Other: visual disturbances, renal and hepatic toxicity usually associated with overdose, renal calculi, jaundice, discoloration of body fluids and aseptic meningitis.

HOW SUPPLIED

Appearance: Reddish-brown, round, film coated tablets debossed “813” on one side and plain on the other.

NDC: 70518-2169-00

NDC: 70518-2169-01

NDC: 70518-2169-02

PACKAGING: 30 in 1 BLISTER PACK

PACKAGING: 6 in 1 BOTTLE PLASTIC

PACKAGING: 21 in 1 BOTTLE PLASTIC

Dispense contents with a child-resistant closure (as required) and in a tight container as defined in the USP.

Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature].

KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN.

Repackaged and Distributed By:

Remedy Repack, Inc.

625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762

Repackaged and Distributed By:

Remedy Repack, Inc.

625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762

DRUG: Phenazopyridine Hydrochloride

GENERIC: Phenazopyridine Hydrochloride

DOSAGE: TABLET, FILM COATED

ADMINSTRATION: ORAL

NDC: 70518-2169-0

NDC: 70518-2169-1

NDC: 70518-2169-2

COLOR: brown

SHAPE: ROUND

SIZE: 10 mm

IMPRINT: 813

PACKAGING: 30 in 1 BLISTER PACK

PACKAGING: 6 in 1 BOTTLE PLASTIC

PACKAGING: 21 in 1 BOTTLE PLASTIC

ACTIVE INGREDIENT(S):

  • PHENAZOPYRIDINE HYDROCHLORIDE 200mg in 1

INACTIVE INGREDIENT(S):

  • CROSCARMELLOSE SODIUM
  • MICROCRYSTALLINE CELLULOSE
  • MAGNESIUM STEARATE
  • POLYETHYLENE GLYCOL, UNSPECIFIED
  • POLYSORBATE 80
  • POLYVINYL ALCOHOL, UNSPECIFIED
  • STARCH, CORN
  • POVIDONE K30
  • TALC
Remedy_Label
(click image for full-size original)
MM2
(click image for full-size original)
MM3
(click image for full-size original)
PHENAZOPYRIDINE HYDROCHLORIDE
phenazopyridine hydrochloride tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70518-2169(NDC:69367-163)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PHENAZOPYRIDINE HYDROCHLORIDE (PHENAZOPYRIDINE) PHENAZOPYRIDINE HYDROCHLORIDE 200 mg
Inactive Ingredients
Ingredient Name Strength
CROSCARMELLOSE SODIUM
MICROCRYSTALLINE CELLULOSE
MAGNESIUM STEARATE
POLYETHYLENE GLYCOL, UNSPECIFIED
POLYSORBATE 80
POLYVINYL ALCOHOL, UNSPECIFIED
STARCH, CORN
POVIDONE K30
TALC
Product Characteristics
Color brown (Reddish-Brown) Score score with uneven pieces
Shape ROUND Size 10mm
Flavor Imprint Code 813
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:70518-2169-0 30 TABLET, FILM COATED in 1 BLISTER PACK None
2 NDC:70518-2169-1 6 TABLET, FILM COATED in 1 BOTTLE, PLASTIC None
3 NDC:70518-2169-2 21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 06/28/2019
Labeler — REMEDYREPACK INC. (829572556)

Revised: 05/2022 REMEDYREPACK INC.

Page 2 of 2 1 2

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.